Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| 1 |
Comcast
CMCSA
|
+$1.02B |
| 2 |
Travelers Companies
TRV
|
+$983M |
| 3 |
TC Energy
TRP
|
+$886M |
| 4 |
Xcel Energy
XEL
|
+$761M |
| 5 |
General Mills
GIS
|
+$716M |
Top Sells
| 1 |
Enbridge
ENB
|
+$1.75B |
| 2 |
Boeing
BA
|
+$1.33B |
| 3 |
Microsoft
MSFT
|
+$1.08B |
| 4 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$1.07B |
| 5 |
Amazon
AMZN
|
+$797M |
Sector Composition
| 1 | Technology | 21.35% |
| 2 | Healthcare | 17.96% |
| 3 | Communication Services | 14.6% |
| 4 | Financials | 13.2% |
| 5 | Industrials | 8.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Intuit
INTU
$182B
| $32.7M | 0.01% |
110,312
-10
| -0% | -$2.96K |
|
327
Axalta
AXTA
$6.69B
| $31.6M | 0.01% |
+1,399,600
| New | +$31.6M |
|
328
Legend Biotech
LEGN
$6.25B
| $29.5M | 0.01% |
+693,588
| New | +$29.5M |
|
329
Liberty Broadband Class C
LBRDK
$8.6B
| $29.3M | 0.01% |
236,682
+40,000
| +20% | +$4.96M |
|
330
Schrodinger
SDGR
$1.36B
| $28.4M | 0.01% |
310,500
-189,500
| -38% | -$17.4M |
|
|
RVNC
331
DELISTED
Revance Therapeutics, Inc.
RVNC
| $28.4M | 0.01% |
1,161,900
| – | – |
|
|
BPY
332
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
| $28.2M | 0.01% |
2,850,550
-825
| -0% | -$8.16K |
|
333
Sturm, Ruger & Co
RGR
$611M
| $27.2M | 0.01% |
357,788
| – | – |
|
|
OCFT
334
OneConnect Financial Technology
OCFT
$280M
| $27.1M | 0.01% |
148,573
+1,960
| +1% | +$358K |
|
335
Phreesia
PHR
$1.4B
| $26.7M | 0.01% |
945,659
+177,159
| +23% | +$5.01M |
|
336
Huazhu Hotels Group
HTHT
$11.3B
| $26.6M | 0.01% |
760,158
| – | – |
|
337
Teradata
TDC
$2.03B
| $26M | 0.01% |
1,248,757
| – | – |
|
338
Cactus
WHD
$2.73B
| $25.8M | 0.01% |
1,249,900
| – | – |
|
339
Bright Horizons
BFAM
$6.21B
| $25.6M | 0.01% |
218,300
| – | – |
|
340
HDFC Bank
HDB
$180B
| $25.6M | 0.01% |
560,584
-290,649
| -34% | -$13.2M |
|
341
Grifois
GRFS
$6.55B
| $24.8M | 0.01% |
1,337,790
+932,601
| +230% | +$17.3M |
|
342
Webster Financial
WBS
$10.1B
| $24.4M | 0.01% |
+851,600
| New | +$24.4M |
|
343
Sarepta Therapeutics
SRPT
$1.83B
| $24.3M | 0.01% |
151,623
+6,895
| +5% | +$1.11M |
|
344
Yext
YEXT
$1.08B
| $24.2M | 0.01% |
1,454,400
| – | – |
|
|
CLLS
345
Cellectis
CLLS
$300M
| $23.8M | 0.01% |
1,339,336
-65,900
| -5% | -$1.17M |
|
346
Pacific Biosciences
PACB
$360M
| $23.4M | 0.01% |
6,796,300
| – | – |
|
|
NARI
347
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $21.8M | 0.01% |
+450,000
| New | +$21.8M |
|
348
Evertec
EVTC
$2.12B
| $20.8M | 0.01% |
741,912
+142,222
| +24% | +$4M |
|
349
Graco
GGG
$14B
| $20.2M | 0.01% |
420,000
| – | – |
|
350
Ross Stores
ROST
$48.1B
| $20.1M | 0.01% |
236,279
-705
| -0.3% | -$60.1K |
|